Fragment-based lead discovery: challenges and opportunities

被引：17
|
作者：
Sun, Chaohong [1 ]
Petros, Andrew M. [1 ]
Hajduk, Philip J. [1 ]
机构：
[1] Abbott Labs, Div Pharmaceut Discovery, Abbott Pk, IL 60064 USA
来源：
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN | 2011年 / 25卷 / 07期
关键词：
Fragment-based drug design; Biologics; Off-shoring; Outsourcing; DRUG DISCOVERY; DESIGN; INHIBITORS; BIOLOGICS; BIG;
D O I：
10.1007/s10822-011-9451-z
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Fragment-based lead discovery has undergone remarkable changes over the last 15 years. During this time, the pharmaceutical industry has changed dramatically as well, and continued evolution of the industry is assured. These changes present many challenges but also several opportunities for executing fragment-based drug design. This article will explore some of the more significant changes in the industry and how they may affect future discovery efforts related to fragment-based initiatives.
引用
收藏
页码：607 / 610
页数：4
相关论文
共 50 条
  • [31] Fragment-based drug discovery
    Warr, Wendy A.
    JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2009, 23 (08) : 453 - 458
  • [32] Fragment-Based Drug Discovery
    Norton, Raymond S.
    AUSTRALIAN JOURNAL OF CHEMISTRY, 2013, 66 (12) : 1463 - 1464
  • [33] Fragment-based discovery in spotlight
    Lipp, Elizabeth
    GENETIC ENGINEERING & BIOTECHNOLOGY NEWS, 2007, 27 (19): : 22 - +
  • [34] Fragment-based lead design
    Tarasova, Olga A.
    Poroikov, V. V.
    RUSSIAN CHEMICAL REVIEWS, 2012, 81 (02) : 158 - 174
  • [35] Fragment-Based Lead Discovery: Screening and Optimizing Fragments for Thermolysin Inhibition
    Englert, Lisa
    Silber, Katrin
    Steuber, Holger
    Brass, Sascha
    Over, Bjoern
    Gerber, Hans-Dieter
    Heine, Andreas
    Diederich, Wibke E.
    Klebe, Gerhard
    CHEMMEDCHEM, 2010, 5 (06) : 930 - 940
  • [36] Hit and Lead Discovery with Explorative RL and Fragment-based Molecule Generation
    Yang, Soojung
    Hwang, Doyeong
    Lee, Seul
    Ryu, Seongok
    Hwang, Sung Ju
    ADVANCES IN NEURAL INFORMATION PROCESSING SYSTEMS 34 (NEURIPS 2021), 2021, 34
  • [37] Electron Density Guided Fragment-Based Lead Discovery of Ketohexokinase Inhibitors
    Gibbs, Alan C.
    Abad, Marta C.
    Zhang, Xuqing
    Tounge, Brett A.
    Lewandowski, Francis A.
    Struble, Geoffrey T.
    Sun, Weimei
    Sui, Zhihua
    Kuo, Lawrence C.
    JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (22) : 7979 - 7991
  • [38] Fragment-based lead discovery on G-protein-coupled receptors
    Visegrady, Andras
    Keseru, Gyorgy M.
    EXPERT OPINION ON DRUG DISCOVERY, 2013, 8 (07) : 811 - 820
  • [39] Novel approach of fragment-based lead discovery applied to renin inhibitors
    Tawada, Michiko
    Suzuki, Shinkichi
    Imaeda, Yasuhiro
    Oki, Hideyuki
    Snell, Gyorgy
    Behnke, Craig A.
    Kondo, Mitsuyo
    Tarui, Naoki
    Tanaka, Toshimasa
    Kuroita, Takanobu
    Tomimoto, Masaki
    BIOORGANIC & MEDICINAL CHEMISTRY, 2016, 24 (22) : 6066 - 6074
  • [40] Fragment-based Discovery of Potential Anticancer Lead: Computational and in vitro Studies
    Balgoname, Abdulmalek A.
    Alomair, Sufyan M.
    AlMubirek, Abdulrahman K.
    Khedr, Mohammed A.
    CURRENT COMPUTER-AIDED DRUG DESIGN, 2021, 17 (03) : 421 - 428
12345